Molecular Residual Disease Interception in Locoregionally-Advanced High Risk HPV+ and HPV- HNSCC

Clinical trial NCT05414032 · RECRUITING

Trial details

NCT number: NCT05414032
Sponsor: University Health Network, Toronto
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)

Start date: 2023-07-12
Primary completion: 2027-09-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.